Erschienen in:
03.11.2017 | Colorectal Cancer
Comment On: Survival and Quality of Life Following Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colonic Origin
verfasst von:
Antonio Pinna, MD, Alan S. Rosman, MD, FACP, Marcovalerio Melis, MD, FACS
Erschienen in:
Annals of Surgical Oncology
|
Sonderheft 3/2017
Einloggen, um Zugang zu erhalten
Excerpt
We read with great interest the article by Hill et al. published in
Annals of Surgical Oncology.
1 We congratulate Dr. Levine’s group as they have brought many contributions to the treatment of peritoneal malignancies, and continue to shed light on this challenging field. In the article, the authors have used several well-validated tools and questionnaires to assess changes in quality of life (QOL) after cytoreductive surgery (CS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for carcinomatosis of colonic origin. Over the course of the 12 months following surgery, little non-significant variation from baseline was observed in QOL scores, with the only exception being emotional well-being. The authors concluded that survival can be attained without major decrements in QOL at 1 year. …